Literature DB >> 17054070

Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.

Ruobing Xiao1, Shu Yang, Fred Koster, Chunyan Ye, Chris Stidley, Brian Hjelle.   

Abstract

To address the role that viral load plays in pathogenesis in patients with hantavirus cardiopulmonary syndrome (HCPS), we quantified Sin Nombre virus S segment viral RNA in plasma samples from 27 acutely ill patients. For 6 patients, we examined viral load in matched plasma, urine, and/or tracheal aspirate throughout the time when the patients were in intensive care. Peak titers in plasma reached 1.8 x 106 copies/mL; none of the patients had viral RNA in urine. Titers in tracheal aspirates did not exceed 8 x 104 copies/mL. We found a statistically significant association (P < .005) between plasma viral RNA levels at admission to the hospital and the severity of disease. Of those with plasma viral RNA titers above the threshold for assay sensitivity (5000 copies/mL), those with mild-moderate and severe disease had an average of 27,800 and 438,545 copies/mL, respectively. These results suggest that patients with high viral loads on admission are more likely to have severe disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054070     DOI: 10.1086/508494

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

Review 2.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

3.  Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment.

Authors:  L Pettersson; T Thunberg; J Rocklöv; J Klingström; M Evander; C Ahlm
Journal:  Clin Microbiol Infect       Date:  2013-06-07       Impact factor: 8.067

4.  Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques.

Authors:  David Safronetz; Joseph Prescott; Friederike Feldmann; Elaine Haddock; Rebecca Rosenke; Atsushi Okumura; Douglas Brining; Eric Dahlstrom; Stephen F Porcella; Hideki Ebihara; Dana P Scott; Brian Hjelle; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.

Authors:  Victoria Wahl-Jensen; Jennifer Chapman; Ludmila Asher; Robert Fisher; Michael Zimmerman; Tom Larsen; Jay W Hooper
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

6.  Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome.

Authors:  Paula Godoy; Delphine Marsac; Elias Stefas; Pablo Ferrer; Nicole D Tischler; Karla Pino; Pablo Ramdohr; Pablo Vial; Pablo D T Valenzuela; Marcela Ferrés; Francisco Veas; Marcelo López-Lastra
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses.

Authors:  Sabine Lederer; Erik Lattwein; Merle Hanke; Karen Sonnenberg; Winfried Stoecker; Åke Lundkvist; Antti Vaheri; Olli Vapalahti; Paul K S Chan; Heinz Feldmann; Daryl Dick; Jonas Schmidt-Chanasit; Paula Padula; Pablo A Vial; Raluca Panculescu-Gatej; Cornelia Ceianu; Paul Heyman; Tatjana Avšič-Županc; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04

8.  Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Natalie A Mackow; Erich R Mackow
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

9.  Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome.

Authors:  Magnus Evander; Irene Eriksson; Lisa Pettersson; Per Juto; Clas Ahlm; Gert E Olsson; Göran Bucht; Annika Allard
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production.

Authors:  Malin Stoltz; Clas Ahlm; Ake Lundkvist; Jonas Klingström
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.